Skip to main content

Guaifenesin and Pseudoephedrine HCl

NDC 70677-1263 · Strategic Sourcing Services LLC

Generic nameGuaifenesin and Pseudoephedrine HCl
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE
Strength600; 60 mg/1; mg/1
Pharmacologic classAdrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]
Marketing categoryANDA

Packages

70677-1263-1 — 1 BLISTER PACK in 1 CARTON (70677-1263-1) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70677-1054 — Guaifenesin, 70677-1055 — Dextromethorphan Hydrobromide / Guaifenesin, 70677-1056 — Guaifenesin/phenylephrine, 70677-1185 — Dextromethorphan HBr, Guaifenesin, 70677-1186 — Guaifenesin, 70677-1187 — Dextromethorphan HBr Guaifenesin Phenylephrine HCl, 70677-1257 — Guaifenesin, 70677-1258 — Guaifenesin, 70677-1259 — Acetaminophen, Guaifenesin, Phenylephrine HCl, 70677-1261 — Dextromethorphan HBr Guaifenesin, 70677-1272 — guaifenesin and pseudoephedrine hydrochloride, 70677-1273 — guaifenesin, pseudoephedrine hydrochloride, 70677-1291 — guaifenesin, 70677-1311 — Cetirizine hydrochloride, Pseudoephedrine hydrochloride, 70677-1315 — fexofenadine hydrochloride, pseudoephedrine hydrochloride, 70692-181 — Dextromethorphan Hydrobromide, Guaifenesin, 70692-836 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, 71179-002 — Guaifenesin, 71179-011 — Guaifenesin and Dextromethorphan HBr, 71179-816 — Naproxen Sodium and Pseudoephedrine Hydrochloride, +1673 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels